| 摘要 |
<p>The present disclosure concerns antigen binding polypeptides and fragments thereof which specifically bind Low-density lipoprotein receptor-related protein 6 (LRP6) particularly human LRP6 (hl_RP6) and which inhibit the binding of Wnt ligands to the LRP6 receptor. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.</p> |
